QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (28) Citing Articles via Google Scholar Google Scholar Articles by Yang, L.-B. Articles by Shen, Y. Search for Related Content PubMed PubMed Citation Articles by Yang, L.-B. Articles by Shen, Y. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information Alzheimer's Disease

 Previous Article  |  Next Article 

The Journal of Neuroscience, October 15, 2000, 20(20):7505-7509

Deficiency of Complement Defense Protein CD59 May Contribute to Neurodegeneration in Alzheimer's Disease

Li-Bang Yang¹, Rena Li¹, Seppo Meri², Joseph Rogers¹, and Yong Shen¹

¹ L. J. Roberts Center for Alzheimer's Research, Sun Health Research Institute, Sun City, Arizona 85351, and ² Department of Immunology, Haartman Institute, University of Helsinki, Finland

Complement defense 59 (CD59) is a cell surface glycophosphoinositol (GPI)-anchored protein that prevents complement membrane attack complex (MAC) assembly. Here, we present evidence from ELISA assays that CD59 protein levels are significantly decreased in the frontal cortex and hippocampus of Alzheimer's disease (AD) compared with nondemented elderly (ND) patients, whereas complement component 9, a final component to form MAC, is significantly increased. To further confirm the CD59 deficit, PI-specific phospholipase C (PIPLC) was used to cleave the CD59 GPI anchor at the cell surface in intact slices from AD and ND cortex. CD59 released by PIPLC cleavage was significantly reduced in AD compared with ND samples. By the use of a ribonuclease protection technique, amyloid -peptide was found to downregulate CD59 expression at the mRNA level, suggesting a partial explanation of CD59 deficits in the AD brain. To evaluate the pathophysiological significance of CD59 alterations in neurons, we exposed cultured NT2 cells, which normally underexpress CD59, and NT2 cells transfected to overexpress CD59 to homologous human serum. Lactic acid dehydrogenase assays revealed significant complement-induced cell lysis in CD59-underexpressing NT2 cells and significant protection from such lysis in CD59-overexpressing NT2 cells. Moreover, cells expressing normal levels of CD59 showed no evidence of MAC assembly or damage after exposure to homologous serum, whereas pretreatment of these cells with a CD59-neutralizing antibody resulted in MAC assembly at the cell surface and morphological damage. Taken together, these data suggest that CD59 deficits may play a role in the neuritic losses characteristic of AD.

Key words: neurodegeneration; Alzheimer; neuron death; amyloid protein; complement; inflammation

---

Copyright © 2000 Society for Neuroscience  0270-6474/00/20207505-05$05.00/0

This article has been cited by other articles:

				P. Yang, J. Tyrrell, I. Han, and G. J. Jaffe Expression and Modulation of RPE Cell Membrane Complement Regulatory Proteins Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3473 - 3481. [Abstract] [Full Text] [PDF]

				J. van Beek, M. van Meurs, B. A. 't Hart, H. P. M. Brok, J. W. Neal, A. Chatagner, C. L. Harris, N. Omidvar, B. P. Morgan, J. D. Laman, et al. Decay-Accelerating Factor (CD55) Is Expressed by Neurons in Response to Chronic but Not Acute Autoimmune Central Nervous System Inflammation Associated with Complement Activation J. Immunol., February 15, 2005; 174(4): 2353 - 2365. [Abstract] [Full Text] [PDF]

				K A Gelderman, H J M A A Zijlmans, M J Vonk, and A Gorter CD55 expression patterns on intestinal neuronal tissue are divergent from the brain Gut, April 1, 2004; 53(4): 507 - 513. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help